Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancers
|
January 28, 2026
Fitness in CLL
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
American Journal of Blood Research
|
April 2, 2021
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma
Francesca Bacchiarri, Vincenzo Sammartano, Adele Santoni, et al.
Frontiers in Cell and Developmental Biology
|
February 23, 2024
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
Ludovica Lopresti, Nagaja Capitani, Vanessa Tatangelo, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Journal of Personalized Medicine
|
March 25, 2022
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network)
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, et al.
Frontiers in Oncology
|
May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
July 4, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4
Vanessa Tatangelo, Gabriele Carullo, Ludovica Lopresti, et al.
Clinical and Experimental Medicine
|
March 7, 2026
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus
Maria D'Amato, Chiara Maria Rapolla, Edoardo Benedetti, et al.
Cell Death & Disease
|
February 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, et al.
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancers
|
January 28, 2026
Fitness in CLL
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
American Journal of Blood Research
|
April 2, 2021
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma
Francesca Bacchiarri, Vincenzo Sammartano, Adele Santoni, et al.
Frontiers in Cell and Developmental Biology
|
February 23, 2024
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
Ludovica Lopresti, Nagaja Capitani, Vanessa Tatangelo, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, et al.
Journal of Personalized Medicine
|
March 25, 2022
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network)
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, et al.
Frontiers in Oncology
|
May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
July 4, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4
Vanessa Tatangelo, Gabriele Carullo, Ludovica Lopresti, et al.
Clinical and Experimental Medicine
|
March 7, 2026
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus
Maria D'Amato, Chiara Maria Rapolla, Edoardo Benedetti, et al.
Cell Death & Disease
|
February 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia
Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, et al.
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
Page
of 3